Acetonitrile

Acetonitrile

SCHEMBL4028413

CC#N.N#CCC(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetonitrile SCHEMBL8026268 1.00 TSHR (0.32)
SCHEMBL141108 0.90
Water SCHEMBL16146969 0.90
Methyl Alcohol SCHEMBL3490957 0.88
Methylene Chloride SCHEMBL7701261 0.84 CYP3A4 (0.35)
Methylene Chloride SCHEMBL3432012 0.84 CYP3A4 (0.35)
Methylene Chloride SCHEMBL8805297 0.84
Methylene Chloride SCHEMBL2207208 0.84 CYP3A4 (0.35)
Methylene Chloride SCHEMBL7211677 0.84 CYP3A4 (0.35)
Acetone SCHEMBL4628352 0.80 MCL1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497265-B1 COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY GLAXO GROUP LTD (GB) 2009-02-18 EP disclosed
US-20050203079-A1 Compounds having affinity at 5ht2C receptor and use thereof in therapy GLAXO GROUP LIMITED 2005-09-15 US disclosed
EP-1497265-A1 COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY GLAXO GROUP LIMITED (GB) 2005-01-19 EP disclosed
WO-2003089409-A1 COMPOUNDS HAVING AFFINITY AT 5HT2C RECEPTOR AND USE THEREOF IN THERAPY GLAXO GROUP LIMITED (GB) 2003-10-30 WO disclosed